Skip to content

SPECT/CT imaging of FPI-2505 in patients with solid tumours; a phase 0 molecular imaging basket trial (SCOPE-study).

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-521235-37-00
Acronym
FPI-2505-001
Enrollment
45
Registered
2025-07-15
Start date
Unknown
Completion date
2025-07-24
Last updated
2025-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer, colorectal cancer, non-smallcell lung cancer, Pancreatic cancer and gastric cancer, small cell lung cancer

Interventions

None listed

Sponsors

Fusion Pharmaceuticals Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026